Latest News - Abbott Laboratories
Top Corporates Hub
Abbott Laboratories
Revolutionizing Cardiology: Robots, AI, and Innovations at the Heart of Change
08.10.2025 11:46
The next-generation intervention cardiology sector is experiencing a transformative shift, leveraging precision-guided, minimally invasive techniques to address complex cardiovascular conditions like coronary artery disease and structural heart defects. This field integrates robotics, AI-powered imaging, and advanced devices, marking a significant move away from traditional open-heart surgeries. With the market projected to reach $46.82 billion by 2035, key players including Abbott, Medtronic, a
Abbott Laboratories (ABT): A Healthcare Leader Powering the List of Profitable Dividend Stocks
08.10.2025 06:19
Abbott Laboratories (NYSE:ABT) is included among the 13 Most Profitable Dividend Stocks to Buy Right Now. Abbott Laboratories (NYSE:ABT) has long been a household name in the healthcare world, offering products that reach millions of people every day. Its operations span several major areas, including prescription medicines, medical devices, diagnostics, and nutrition. The company’s portfolio […]
The Zacks Analyst Blog Highlights Advanced Micro Devices, Abbott Laboratories and Micron Technology
06.10.2025 13:50
AMD, Abbott and Micron showcase strong momentum as AI demand, medical innovation and memory recovery drive growth prospects.
Abbott Laboratories (ABT) Maintains Strong MedTech Growth Outlook
02.10.2025 06:33
Abbott Laboratories (NYSE:ABT) ranks among the top picks for a retirement portfolio. UBS maintained Abbott Laboratories (NYSE:ABT) as a top choice in the Medical Supplies and Devices industry on September 23, reaffirming its Buy rating on the company’ shares with a price target of $154. The firm expressed strong confidence in the company’s future trajectory, […]
2 Profitable Stocks to Consider Right Now and 1 We Find Risky
02.10.2025 04:40
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
Synlait Milk agrees North Island asset sale to Abbott Laboratories
29.09.2025 13:32
The assets, including the Pokeno factory, amount to around half of Synlait’s average market capitalisation.
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It
29.09.2025 13:00
Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Abbott's Dissolving Stent Receives Health Canada Approval for Treating Blocked Arteries Below-the-Knee
29.09.2025 12:00
Abbott (NYSE: ABT) today announced that Health Canada has authorized the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a first-of-its kind treatment innovation for people with chronic limb threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug, everolimus, to support vessel healing prior to completely dissolving.
What to Expect From Abbott Laboratories' Next Quarterly Earnings Report
29.09.2025 09:46
Abbott Laboratories will release its third-quarter earnings next month, and analysts anticipate a single-digit bottom-line growth.
Growing Diagnostics Arm Supports ABT Stock, Macro Issues Ail
26.09.2025 12:41
ABT gains momentum with strong FreeStyle Libre sales and Diagnostics growth but global macro headwinds weigh on performance.
Is Abbott Laboratories' (NYSE:ABT) Recent Performance Tethered To Its Attractive Financial Prospects?
26.09.2025 11:00
Most readers would already know that Abbott Laboratories' (NYSE:ABT) stock increased by 1.3% over the past month. Given...
Blood Collection Market Forecast and Competitive Strategy Report 2025-2033: Abbott, BD, Roche and Siemens Healthineers Lead as Global Players Drive Innovation and Integrated Solutions
24.09.2025 08:09
The blood collection market offers growth opportunities driven by increased demand for automated systems, expanding diagnostic and treatment applications, and personalized medicine. Key regions include North America, Europe, and emerging Asia-Pacific markets, supported by advancements in technologies and healthcare infrastructure improvements.Dublin, Sept. 24, 2025 (GLOBE NEWSWIRE) -- The "Blood Collection Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Play
Pivot Bio CEO to Spotlight the Commercial Opportunity of Sustainability and Innovation in Agriculture at Climate Week NYC
20.09.2025 02:31
Pivot Bio, one of the world's most innovative agtech companies, will take center stage during Climate Week in New York City (Sept. 22–24). CEO Chris Abbott will join global business and sustainability leaders to highlight how agriculture is advancing climate solutions, reducing costs and strengthening the economic resilience of rural communities.
Abbott warns of package-induced damage of ablation catheters
19.09.2025 16:02
While there have been no injuries as of yet, the FDA said it is monitoring this “potentially high-risk issue.”
Smart Medical Devices Market Size to Reach $180.4 Billion by 2033 - Strategic Growth Opportunities in Chronic Disease Management, Digital Health, and Connected Care
19.09.2025 15:30
The Smart Medical Devices Market Size valued at US$ 61.7 billion in 2024, is projected to reach US$ 180.4 billion by 2033, expanding at a CAGR of 12.8% (2025–2033), according to the latest report from DataM Intelligence.
Abbott Declares 407th Consecutive Quarterly Dividend
19.09.2025 14:00
The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 59 cents per share.
FDA posts early alert about Abbott’s Tactiflex Ablation Catheter
19.09.2025 02:41
Catheter tips came off three damaged devices during surgery but none of the patients suffered serious injuries or died.
Is Abbott Laboratories (NYSE:ABT) Using Too Much Debt?
17.09.2025 14:00
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Hemato-Oncology Testing Market Size, Share & Trends Analysis Report 2025-2030 Featuring Key Players Roche, Abbott, EntroGen, Qiagen, and Cepheid (Danaher) Among Others
02.09.2025 12:59
Opportunities in the hemato-oncology testing market include rising lymphoma and myeloma cases, personalized therapy demand, and advanced molecular diagnostics. Emerging technologies like single-cell sequencing and long-read sequencing enhance diagnostic precision, thus driving market growth and improving patient outcomes. Hemato Oncology Testing Market Hemato Oncology Testing Market Dublin, Sept. 02, 2025 (GLOBE NEWSWIRE) -- The "Hemato-Oncology Testing Market Size, Share & Trends Analysis 2025-